FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.70
−4.94%Margins
Gross margin
17.1%
EBITDA margin
3.0%
EBIT margin
0.4%
Net margin
-3.2%
FCF margin
5.6%
-16.3%
Return on equity
-3.1%
Return on assets
0.7%
Return on invested capital
0.99x
Asset turnover
$182.4M
Cash from operations
$1.77
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026